Vertex Pharmaceuticals files for mixed shelf offering
tupungato/iStock via Getty Images


Vertex Pharmaceuticals (NASDAQ:VRTX) has filed for a mixed shelf offering, though the amount has yet to be determined.
The filing does not necessarily indicate that a sale has begun, or will occur in the future.
Vertex intends to use the proceeds from a potential offering for general corporate purposes, including the financing of our operations, possible repayment of indebtedness, and possible business acquisitions.
The offering can include common stock, debt securities, preferred stock, warrants, subscriptions rights, purchase contracts, and purchase units.
Check out Vertex's Q4 2021 results from last month.